Pregled bibliografske jedinice broj: 216346
Major congenital malformations and 22q11.2 microdeletion
Major congenital malformations and 22q11.2 microdeletion // Book of Abstracts of the 8th European Symposium on Prevention of Congenital Anomalies ; u: Archives of Perinatal Medicine. Supplement (2005) (S)
Poznań, Poljska, 2005. str. 19-19 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 216346 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Major congenital malformations and 22q11.2 microdeletion
(Major congenital malforamtions and 22q11.2 microdeletion)
Autori
Barišić, Ingeborg ; Morožin-Pohovski, Leona ; Petković, Iskra
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Book of Abstracts of the 8th European Symposium on Prevention of Congenital Anomalies ; u: Archives of Perinatal Medicine. Supplement (2005) (S)
/ - , 2005, 19-19
Skup
European Symposium on Prevention of congenital Anomalies (8 ; 2005)
Mjesto i datum
Poznań, Poljska, 09.06.2005. - 10.06.2005
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
major congenital malformations; 22q11.2 microdeletion
Sažetak
Background: Congenital heart defects (CHD) are the most common of all human birth defects occurring in 1% of live births. Previous studies suggest that a number of patients with congenital heart disease have a 22q11.2 deletion syndrome (22q11.2 DS). Orofacial clefts are also among the most common major congenital anomalies and are included in the 22q11.2 clinical spectrum. The clinical phenotype of 22q11.2 DS is highly variable. Patients with mild clinical manifestations and apparently isolated malformation can be easily overlooked. Objective: To determine should the 22q11.2 deletion analysis become a part of the standardized diagnostic workup for CHD and orofacial clefts. Methods and patients: A consecutive series of one hundred twenty-two patients with two selected major malformations, CHD (64 patients) and orofacial clefts (58 patients) were prospectively enrolled into the study and screened for the presence of a 22q11 deletion. Detailed clinical evaluation, high-resolution chromosome and FISH analysis were performed. Results: Deletions at 22q11.2 were detected in 9.4% (6/64) patients with CHD. In the subgroup of patients with conotruncal anomalies, 22q11.2 deletion was present in 17.8% (5/28) patients. None of the 58 patients with palatal abnormalities had a deletion. Conclusions: Testing is recommended for patients with conotruncal heart defects, because a substantial proportion has a 22q11.2 deletion. Deletion testing of children with other cardiac defects should be considered in the presence of additional features of 22q11.2 DS. A routine screening for the 22q11.2 deletion in children with isolated palatal anomalies may not be justified.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti